3,3',4,5'-tetrahydroxystilbene
(CDRPUGZCRXZLFL-OWOJBTEDSA-N)
Structure
- SMILES
- Oc1cc(/C=C/c2ccc(c(c2)O)O)cc(c1)O
- Type(s)
- Experimental
- Molecular Formula:
- C14H12O4
- Molecular Weight:
- 244.243
- Log P:
- 2.6794
- Hydrogen Bond Acceptor:
- 4
- Hydrogen Bond Donor:
- 4
- TPSA:
- 80.92
- CAS Number(s):
- 4339-71-3; 10083-24-6
Synonym(s)
1.
3,3',4,5'-tetrahydroxystilbene
2.
3'-hydroxyresveratol
3.
3,3',4',5-tetrahydroxystilbene
4.
3,3',4,5'-tetrahydroxy stilbene
5.
3,5,3',4'-tetrahydroxy-stilbene
6.
3,5,3',4'-tetrahydroxy-trans-stilbene
7.
3,5,3',4'-tetrahydroxystilbene
8.
RSVL-1
9.
astringinin
10.
demethyl isorhapontigenin
11.
piceatannol
12.
piceatanol
External Link(s)
| MeSH | C041525 |
| PubChem Compound | 667639 |
| BindingDB | 50045936 |
| ChEBI | 28814 92460 |
| CHEMBL | CHEMBL69863 |
| DrugBank | DB08399 |
| KEGG | cpd:C05901 |
| Therapeutic Target Database | D0O0VZ |
| ZINC | 14036 |
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Cardiomegaly | 31323227 | CTD | |
| 2 | Colitis | 20155626 | CTD | |
| 3 | Diabetic Cardiomyopathies | 31323227 | CTD | |
| 4 | Drug Eruptions | 23426871 | CTD | |
| 5 | Endomyocardial Fibrosis | 31323227 | CTD | |
| 6 | Hyperglycemia | 31323227 | CTD | |
| 7 | Inflammation | 23426871 | CTD | |
| 8 | Mammary Neoplasms, Experimental | 11962253 | CTD | |
| 9 | Neoplasm Invasiveness | 23877152 | CTD | |
| 10 | Neoplasm Metastasis | 23877152 | CTD | |
| 11 | Neoplasms | 20155627 | CTD | |
| 12 | Neurotoxicity Syndromes | 23712764 | CTD | |
| 13 | Prostatic Neoplasms | 24610083 | CTD | |
| 14 | Thrombosis | 12606772 | CTD | |
| 15 | Ventricular Dysfunction, Left | 31323227 | CTD | |
| 16 | anaphylaxis | 23426871 | CTD |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.